These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9831913

  • 1. The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
    Pickavance L, Widdowson PS, King P, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Oct; 125(4):767-70. PubMed ID: 9831913
    [Abstract] [Full Text] [Related]

  • 2. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [Abstract] [Full Text] [Related]

  • 3. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
    Wargent E, Stocker C, Augstein P, Heinke P, Meyer A, Hoffmann T, Subramanian A, Sennitt MV, Demuth HU, Arch JR, Cawthorne MA.
    Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise.
    Király MA, Bates HE, Yue JT, Goche-Montes D, Fediuc S, Park E, Matthews SG, Vranic M, Riddell MC.
    Metabolism; 2007 Jun; 56(6):732-44. PubMed ID: 17512304
    [Abstract] [Full Text] [Related]

  • 5. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
    Sugimoto K, Rashid IB, Kojima K, Shoji M, Tanabe J, Tamasawa N, Suda T, Yasujima M.
    Diabetes Metab Res Rev; 2008 Jun; 24(8):642-50. PubMed ID: 18973207
    [Abstract] [Full Text] [Related]

  • 6. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM, Risovic V, Yuen VG, McNeill JH.
    J Trace Elem Med Biol; 2006 Jun; 19(4):251-8. PubMed ID: 16443173
    [Abstract] [Full Text] [Related]

  • 7. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
    Suh YH, Kim Y, Bang JH, Choi KS, Lee JW, Kim WH, Oh TJ, An S, Jung MH.
    J Mol Endocrinol; 2005 Apr; 34(2):299-315. PubMed ID: 15821098
    [Abstract] [Full Text] [Related]

  • 8. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
    Bates HE, Kiraly MA, Yue JT, Goche Montes D, Elliott ME, Riddell MC, Matthews SG, Vranic M.
    Metabolism; 2007 Aug; 56(8):1065-75. PubMed ID: 17618951
    [Abstract] [Full Text] [Related]

  • 9. Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats.
    Yuen VG, Bhanot S, Battell ML, Orvig C, McNeill JH.
    Can J Physiol Pharmacol; 2003 Nov; 81(11):1049-55. PubMed ID: 14719040
    [Abstract] [Full Text] [Related]

  • 10. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T, Jazbutyte V, Arias-Loza PA, Segerer S, Lichtenwald M, Law MP, Schäfers M, Ertl G, Neyses L.
    Biochem Biophys Res Commun; 2005 Apr 08; 329(2):726-32. PubMed ID: 15737646
    [Abstract] [Full Text] [Related]

  • 11. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.
    Lee Y, Kwon MK, Kang ES, Park YM, Choi SH, Ahn CW, Kim KS, Park CW, Cha BS, Kim SW, Sung JK, Lee EJ, Lee HC.
    J Gene Med; 2008 Mar 08; 10(3):260-8. PubMed ID: 18085721
    [Abstract] [Full Text] [Related]

  • 12. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
    Clerk LH, Vincent MA, Barrett EJ, Lankford MF, Lindner JR.
    Am J Physiol Endocrinol Metab; 2007 Dec 08; 293(6):E1804-9. PubMed ID: 17911341
    [Abstract] [Full Text] [Related]

  • 13. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.
    Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA.
    Am J Physiol Endocrinol Metab; 2005 Jul 08; 289(1):E113-22. PubMed ID: 15727946
    [Abstract] [Full Text] [Related]

  • 14. In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight.
    Janssen SW, Martens GJ, Sweep CG, Ross HA, Hermus AR.
    Horm Metab Res; 1999 Nov 08; 31(11):610-5. PubMed ID: 10598829
    [Abstract] [Full Text] [Related]

  • 15. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
    Smith SA, Lister CA, Toseland CD, Buckingham RE.
    Diabetes Obes Metab; 2000 Dec 08; 2(6):363-72. PubMed ID: 11225966
    [Abstract] [Full Text] [Related]

  • 16. Reduced expression of the KATP channel subunit, Kir6.2, is associated with decreased expression of neuropeptide Y and agouti-related protein in the hypothalami of Zucker diabetic fatty rats.
    Gyte A, Pritchard LE, Jones HB, Brennand JC, White A.
    J Neuroendocrinol; 2007 Dec 08; 19(12):941-51. PubMed ID: 18001323
    [Abstract] [Full Text] [Related]

  • 17. Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound.
    Clark TA, Edel AL, Heyliger CE, Pierce GN.
    Can J Physiol Pharmacol; 2004 Oct 08; 82(10):888-94. PubMed ID: 15573149
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
    van Poelje PD, Potter SC, Chandramouli VC, Landau BR, Dang Q, Erion MD.
    Diabetes; 2006 Jun 08; 55(6):1747-54. PubMed ID: 16731838
    [Abstract] [Full Text] [Related]

  • 19. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F, Abdallah P, Basset A, del Carmine P, Haffar G, Beylot M.
    Obesity (Silver Spring); 2009 Jul 08; 17(7):1381-9. PubMed ID: 19553925
    [Abstract] [Full Text] [Related]

  • 20. Age-dependent development of metabolic derangement and effects of intervention with pioglitazone in Zucker diabetic fatty rats.
    Szöcs Z, Brunmair B, Stadlbauer K, Nowotny P, Bauer L, Luger A, Fürnsinn C.
    J Pharmacol Exp Ther; 2008 Jul 08; 326(1):323-9. PubMed ID: 18445783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.